Clinical Trial Update: China Surpass Streamline Post-Market Study

View source ↗

Summary

A post-market study of the Streamline device for intracranial aneurysm by Stryker Neurovascular in China has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm

Drugs mentioned

• Streamline

Snippet

Sponsor: Stryker Neurovascular | Conditions: Aneurysm, Intracranial | Status: TERMINATED